Maynard Um
-
-
-
-
-
-
-
Elevation Oncology (ELEV) Presents Preclinical Proof-of-Concept Data for EO-1022
-
-
-
-
-
-
-
Elevation Oncology, Inc. (ELEV) Tops Q4 EPS by 4c
-
-
-
-
-
-
-
Elevation Oncology (ELEV) Reports Promising Initial Data from Phase 1 Trial of EO-3021
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

